White House doubles down on call to fund FDA entirely with industry fees
WASHINGTON, DC — Following the House of Representatives’ passage of the bill to reauthorize FDA user fees on Wednesday, the White House doubled down on its earlier call to amend the agreements so that FDA is entirely funded by medical products industries.
“The Administration urges the Congress to provide for 100 percent user fee funding within the reauthorized programs,” the White House said in a statement. “In an era of renewed fiscal restraint, industries that benefit directly from FDA’s work should pay for it.”
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.
